ASTOUNDCOMMERCE.COM ASTOUND HEALTH REPORT 2023 + Digital Therapeutics From insomnia to chronic back pain to substance therapeutics in the past year, that number rose to + abuse disorders, digital therapeutics, the growing almost 30 percent among respondents under 35. Although few have used these field of “software as medical devices,” are offering Across age demographics, two-thirds (66 percent) of pioneering digital therapies, health consumers exciting new options for tracking respondents indicated they are open to using digital consumer interest and and managing conditions traditionally treated by therapeutics. The biggest obstacle to adoption was appetite is high drugs or in-person therapies. Still in its infancy, the a preference for talking to someone in person—more industry was valued at US$3.02 billion in 2021 communication from companies about how digital and is expected to experience an impressive 31.4 therapeutics function, to supplement rather than 6 percent CAGR over the next decade. Although fewer replace working with a healthcare provider, might than one in five respondents reported using digital persuade more patients of their value. Current Use Future Use YES NO YES NO GLOBAL 18% 82% GLOBAL 66% 34% NORTH 11% 89% NORTH 59% 41% AMERICA AMERICA EUROPE 24% 76% EUROPE 70% 30% UK 12% 88% UK 57% 43% LATAM 37% 63% LATAM 90% 10% MENA 27% 73% MENA 82% 18% Figure 18: Respondents who report having ever used digital therapeutics, by region. Figure 20: Respondents who would consider using digital therapeutics in the future, by region. 18–24 25–34 35–44 45–54 55–64 65+ 18–24 25–34 35–44 45–54 55–64 65+ YES 29% 30% 20% 10% 6% 3% YES 71% 73% 73% 69% 64% 35% NO 71% 70% 80% 90% 94% 97% NO 29% 27% 27% 31% 36% 65% Figure 19: Respondents who report having ever used digital therapeutics, by age. Figure 21: Respondents who would consider using digital therapeutics in the future, by age. 28 29